A detailed history of Vigilant Capital Management, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Vigilant Capital Management, LLC holds 418,805 shares of AZN stock, worth $30.5 Million. This represents 2.24% of its overall portfolio holdings.

Number of Shares
418,805
Previous 419,008 0.05%
Holding current value
$30.5 Million
Previous $29.1 Million 3.06%
% of portfolio
2.24%
Previous 2.36%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 08, 2023

SELL
$69.91 - $75.81 $14,191 - $15,389
-203 Reduced 0.05%
418,805 $30 Million
Q1 2023

May 01, 2023

SELL
$63.15 - $71.6 $533,806 - $605,234
-8,453 Reduced 1.98%
419,008 $29.1 Million
Q4 2022

Jan 26, 2023

SELL
$54.21 - $70.44 $450,051 - $584,792
-8,302 Reduced 1.91%
427,461 $29 Million
Q3 2022

Oct 25, 2022

SELL
$53.02 - $135.75 $148,562 - $380,371
-2,802 Reduced 0.64%
435,763 $23.9 Million
Q2 2022

Jul 06, 2022

SELL
$59.26 - $71.14 $138,549 - $166,325
-2,338 Reduced 0.53%
438,565 $29 Million
Q1 2022

Apr 07, 2022

BUY
$55.72 - $67.12 $537,085 - $646,969
9,639 Added 2.24%
440,903 $29.3 Million
Q4 2021

Jan 06, 2022

BUY
$54.02 - $63.83 $1.62 Million - $1.91 Million
29,955 Added 7.46%
431,264 $25.1 Million
Q3 2021

Oct 08, 2021

BUY
$55.56 - $60.79 $1.6 Million - $1.75 Million
28,781 Added 7.73%
401,309 $24.1 Million
Q2 2021

Jul 09, 2021

BUY
$48.42 - $60.18 $231,931 - $288,262
4,790 Added 1.3%
372,528 $22.3 Million
Q1 2021

Apr 16, 2021

BUY
$47.16 - $54.44 $641,564 - $740,601
13,604 Added 3.84%
367,738 $18.3 Million
Q4 2020

Jan 14, 2021

BUY
$48.52 - $58.02 $610,575 - $730,123
12,584 Added 3.68%
354,134 $17.7 Million
Q3 2020

Oct 15, 2020

BUY
$53.07 - $61.1 $551,131 - $634,523
10,385 Added 3.14%
341,550 $18.7 Million
Q2 2020

Jul 10, 2020

BUY
$43.1 - $55.31 $151,194 - $194,027
3,508 Added 1.07%
331,165 $17.5 Million
Q1 2020

Apr 17, 2020

BUY
$37.79 - $51.33 $418,335 - $568,223
11,070 Added 3.5%
327,657 $14.6 Million
Q4 2019

Jan 17, 2020

SELL
$42.46 - $50.46 $107,211 - $127,411
-2,525 Reduced 0.79%
316,587 $15.8 Million
Q3 2019

Oct 16, 2019

BUY
$40.12 - $45.47 $507,798 - $575,513
12,657 Added 4.13%
319,112 $14.2 Million
Q2 2019

Jul 18, 2019

BUY
$37.28 - $41.68 $987,733 - $1.1 Million
26,495 Added 9.46%
306,455 $12.7 Million
Q1 2019

Apr 09, 2019

BUY
$35.49 - $43.02 $9.91 Million - $12 Million
279,160 Added 34895.0%
279,960 $11.3 Million
Q2 2018

Jul 11, 2018

SELL
$34.55 - $37.05 $7,186 - $7,706
-208 Reduced 20.63%
800 $28,000
Q1 2018

Apr 04, 2018

BUY
$32.97 - $36.63 $6,857 - $7,619
208 Added 26.0%
1,008 $35,000
Q3 2017

Oct 13, 2017

BUY
$28.96 - $34.0 $23,168 - $27,200
800
800 $27,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $226B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Vigilant Capital Management, LLC Portfolio

Follow Vigilant Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vigilant Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vigilant Capital Management, LLC with notifications on news.